From Diagnosis to Treatment: Understanding Haemophilia and the Care It Requires

 Haemophilia is an uncommon genetic condition whereby the affected individual’s blood cannot clot because there are deficiencies in certain proteins necessary for the process. Early diagnosis and regular treatment with factor or special blood components are critical for avoiding lifelong joint damage and other serious bleeding complications.

What You Need to Know About Haemophilia 

Coagulation involves a complex series of interactions between blood proteins referred to as clotting factors. The lack of one of these clotting factors results in delayed clot formation, causing excessive bleeding from any wounds sustained, muscle haemorrhages, and joint haemorrhage (haemarthrosis).

Although haemophilia is generally diagnosed at birth or early childhood as a lifelong genetic disorder, there are different types of haemophilia, depending on which clotting factor is involved.

The Primary Types and Classifications

Haemophilia is categorized into different types depending on the underlying factor deficiency:

• Classic Haemophilia: The most frequent one that makes up 80% to 85% of all haemophilia cases. It is an X-linked recessive disorder characterized by either deficiency or faulty function of Clotting Factor VIII (FVIII).

• Christmas Disease: The second most frequent one, also X-linked, caused by deficiency of Clotting Factor IX (FIX). This kind of haemophilia is clinically the same as Classic Haemophilia but needs a totally different factor replacement treatment.

• Factor XI Deficiency: A rare case caused by a deficiency of Factor XI (FXI). Contrary to Types A and B, this kind is autosomal (inherited by both females and males) and usually shows mild symptoms with no spontaneous joint bleeding.

• Acquired Haemophilia: A rare and non-genetic condition which implies production of autoantibodies against one's own clotting factors (Factor VIII, mostly) by the immune system.

Across Haemophilia A and B, severity is classified by plasma factor activity: mild (5% to 40% activity), moderate (1% to 5%), or severe (less than 1%), with severe cases frequently experiencing spontaneous bleeding into major joints like knees, ankles, and elbows.

Diagnosis and Modern Treatment Modalities

Effective management requires accurate laboratory assessment and rapid intervention during bleeding episodes:

1. Laboratory Profiling: The first step of laboratory investigation usually shows a single prolonged test, which is APTT, while PT and platelets are within the normal range. After that, one can proceed with the confirmation of the missing factor via assays and identify the precise percentage of it.

2. Clotting Factor Concentrates (CFCs): The modern standard for treatment is the intravenous administration of recombinant or plasma-derived Factor VIII or Factor IX concentrates either "on-demand" to stop the bleeding process or for prophylaxis of joint bleeds.

3. Blood components (FFP & Cryoprecipitate): When commercial factor concentrates are not available due to some resource limitation, then FFP and cryoprecipitate (high content of Factor VIII and fibrinogen) become crucial for survival.

4. Physiotherapy and orthopaedic rehabilitation: Routine rehabilitation helps to maintain the joint range of motion and strengthen the muscles around joints to prevent haemophilic arthropathy.

Fatimid: Leading Comprehensive Haemophilia Care in Karachi

Continuous and free access to hematological treatment is one of the biggest problems faced by poor families in Karachi and throughout Pakistan. Fatimid Foundation provides charitable and specialized haemophilia treatment in Karachi 

Fatimid Foundation runs a center in Karachi where it offers its registered haemophilia sufferers free-of-charge clinical treatment, coagulation analysis, and factor concentrates administration. Through providing and administering safe and screened blood products (cryoprecipitate and fresh plasma along with factor concentrates), Fatimid Foundation is able to prevent lifelong disabilities and dangerous internal bleeds.

FAQs

What should be done immediately when a haemophilia patient experiences a joint bleed?

Infuse the prescribed clotting factor concentrate as quickly as possible. Along with factor administration, apply the R.I.C.E. protocol: Rest the affected limb, Ice (wrapped in a cloth, never direct ice on skin), Compress gently, and Elevate the joint above heart level. Never administer aspirin or NSAIDs like ibuprofen, as they impair platelet function and worsen bleeding.

Where can patients receive subsidized or free haemophilia treatment in Karachi?

Patients can access free haemophilia treatment in Karachi at Fatimid Foundation.

Conclusion

Living with hemophilia entails continuous watchfulness, correct diagnosis, and timely treatment by medical professionals. Hemophilia may still be a chronic and hereditary condition, but timely provision of prophylactic treatment, modern factor therapy, and bleeding control helps turn it into a manageable condition. Thanks to nonprofit healthcare organizations such as Fatimid Foundation, the residents of Karachi, Pakistan, are provided with all the required treatments and care that can save their lives.